New Risk • Jun 07
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended December 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2024 fiscal period end). Revenue is less than US$1m (€541k revenue, or US$624k). Market cap is less than US$10m (€4.12m market cap, or US$4.75m). New Risk • Jan 16
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Revenue is less than US$1m (€541k revenue, or US$628k). Market cap is less than US$10m (€4.26m market cap, or US$4.94m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). New Risk • Dec 22
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (€541k revenue, or US$633k). Market cap is less than US$10m (€5.05m market cap, or US$5.92m). Minor Risk Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). 공시 • Jul 06
Horus AG, Annual General Meeting, Aug 13, 2025 Horus AG, Annual General Meeting, Aug 13, 2025, at 15:00 W. Europe Standard Time. New Risk • Jan 12
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 73% over the past year. Revenue is less than US$1m (€192k revenue, or US$197k). Market cap is less than US$10m (€3.72m market cap, or US$3.82m). Minor Risk Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). New Risk • Jan 01
New major risk - Revenue and earnings growth Revenue has declined by 73% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Revenue has declined by 73% over the past year. Revenue is less than US$1m (€192k revenue, or US$199k). Market cap is less than US$10m (€5.59m market cap, or US$5.79m). New Risk • Aug 17
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Revenue is less than US$1m (€192k revenue, or US$211k). Market cap is less than US$10m (€3.19m market cap, or US$3.52m). 공시 • Jul 05
Horus AG, Annual General Meeting, Aug 19, 2024 Horus AG, Annual General Meeting, Aug 19, 2024, at 15:00 W. Europe Standard Time. New Risk • Jun 09
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended December 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2022 fiscal period end). Revenue has declined by 29% over the past year. Revenue is less than US$1m (€715k revenue, or US$773k). Market cap is less than US$10m (€3.33m market cap, or US$3.59m). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (38% net profit margin). Buy Or Sell Opportunity • Mar 13
Now 26% overvalued Over the last 90 days, the stock has fallen 33% to €1.20. The fair value is estimated to be €0.95, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 29% over the last year. Earnings per share has declined by 73%. Buy Or Sell Opportunity • Feb 16
Now 24% overvalued Over the last 90 days, the stock has fallen 37% to €1.20. The fair value is estimated to be €0.97, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 29% over the last year. Earnings per share has declined by 73%. Buy Or Sell Opportunity • Jan 30
Now 100% undervalued after recent price drop Over the last 90 days, the stock has fallen 100% to €0.0005. The fair value is estimated to be €0.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 29% over the last year. Earnings per share has declined by 73%. Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment deteriorates as stock falls 26% After last week's 26% share price decline to €1.40, the stock trades at a trailing P/E ratio of 13.6x. Average trailing P/E is 24x in the Capital Markets industry in Germany. Total returns to shareholders of 7.7% over the past three years. New Risk • Dec 25
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 6.2% per year over the past 5 years. Revenue is less than US$1m (€715k revenue, or US$788k). Market cap is less than US$10m (€4.79m market cap, or US$5.27m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (38% net profit margin). Valuation Update With 7 Day Price Move • Sep 19
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to €1.85, the stock trades at a trailing P/E ratio of 18x. Average trailing P/E is 22x in the Capital Markets industry in Germany. Total returns to shareholders of 22% over the past three years. Valuation Update With 7 Day Price Move • Aug 06
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to €1.42, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 19x in the Capital Markets industry in Germany. Total returns to shareholders of 5.2% over the past three years. Valuation Update With 7 Day Price Move • Jul 20
Investor sentiment improves as stock rises 33% After last week's 33% share price gain to €1.90, the stock trades at a trailing P/E ratio of 18.5x. Average trailing P/E is 17x in the Capital Markets industry in Germany. Total returns to shareholders of 46% over the past three years. Valuation Update With 7 Day Price Move • Jul 04
Investor sentiment deteriorates as stock falls 28% After last week's 28% share price decline to €1.40, the stock trades at a trailing P/E ratio of 13.6x. Average trailing P/E is 18x in the Capital Markets industry in Germany. Total returns to shareholders of 7.7% over the past three years. New Risk • Jun 12
New major risk - Revenue size The company makes less than US$1m in revenue. Total revenue: €838k (US$901k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 6.2% per year over the past 5 years. Revenue is less than US$1m (€838k revenue, or US$901k). Market cap is less than US$10m (€5.05m market cap, or US$5.43m). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (33% net profit margin). Valuation Update With 7 Day Price Move • Jun 10
Investor sentiment improves as stock rises 36% After last week's 36% share price gain to €1.90, the stock trades at a trailing P/E ratio of 5x. Average trailing P/E is 17x in the Capital Markets industry in Germany. Total returns to shareholders of 46% over the past three years. Valuation Update With 7 Day Price Move • May 09
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to €1.40, the stock trades at a trailing P/E ratio of 3.7x. Average trailing P/E is 16x in the Capital Markets industry in Germany. Total returns to shareholders of 15% over the past three years. Valuation Update With 7 Day Price Move • Apr 20
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to €1.80, the stock trades at a trailing P/E ratio of 4.7x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total returns to shareholders of 48% over the past three years. Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to €1.80, the stock trades at a trailing P/E ratio of 4.7x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total returns to shareholders of 78% over the past three years. Valuation Update With 7 Day Price Move • Jan 24
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to €1.40, the stock trades at a trailing P/E ratio of 3.7x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Negligible returns to shareholders over past three years. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment deteriorated over the past week After last week's 24% share price decline to €1.30, the stock trades at a trailing P/E ratio of 3.4x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total loss to shareholders of 7.8% over the past three years. Valuation Update With 7 Day Price Move • Dec 22
Investor sentiment deteriorated over the past week After last week's 17% share price decline to €2.00, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total returns to shareholders of 18% over the past three years. Valuation Update With 7 Day Price Move • Dec 01
Investor sentiment improved over the past week After last week's 35% share price gain to €2.70, the stock trades at a trailing P/E ratio of 7.1x. Average trailing P/E is 9x in the Capital Markets industry in Germany. Total returns to shareholders of 74% over the past three years. Valuation Update With 7 Day Price Move • Oct 21
Investor sentiment improved over the past week After last week's 64% share price gain to €1.80, the stock trades at a trailing P/E ratio of 4.7x. Average trailing P/E is 10x in the Capital Markets industry in Germany. Total returns to shareholders of 5.9% over the past three years. Is New 90 Day High Low • Jan 21
New 90-day low: €1.40 The company is down 8.0% from its price of €1.52 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 13% over the same period. Is New 90 Day High Low • Dec 23
New 90-day high: €1.60 The company is up 5.0% from its price of €1.52 on 23 September 2020. The German market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 8.0% over the same period. Is New 90 Day High Low • Oct 13
New 90-day high: €1.53 The company is up 18% from its price of €1.30 on 15 July 2020. The German market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 7.0% over the same period.